Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice.
- DOI
- 10.1007/s10067-019-04535-z
- Published
- 2019 Sep
- Container
- Clinical rheumatology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10067-019-04535-z,
title = {Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice.},
author = {Bykerk VP and Östör AJK and Alvaro-Gracia J and Pavelka K and Román Ivorra JA and Nurmohamed MT and Luder Y and Sidiropoulos PNM and Devenport J and Sibilia J},
year = {2019},
journal = {Clinical rheumatology},
doi = {10.1007/s10067-019-04535-z},
url = {https://doi.org/10.1007/s10067-019-04535-z}
}RIS
TY - JOUR TI - Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice. AU - Bykerk VP AU - Östör AJK AU - Alvaro-Gracia J AU - Pavelka K AU - Román Ivorra JA AU - Nurmohamed MT AU - Luder Y AU - Sidiropoulos PNM AU - Devenport J AU - Sibilia J PY - 2019 JO - Clinical rheumatology DO - 10.1007/s10067-019-04535-z UR - https://doi.org/10.1007/s10067-019-04535-z ER -
APA
VP, B., AJK, Ö., J, A., K, P., JA, R. I., MT, N., Y, L., PNM, S., J, D., & J, S. (2019). Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice.. Clinical rheumatology. https://doi.org/10.1007/s10067-019-04535-z
Source records
- pubmed · retrieved 2026-09-25T08:16:48.937Z